A new conceptual inhaler designed around the idea of controlled microdosing could eventually lead to a product capable of administering precise amounts of active ingredients such as CBD, nicotine or even psychedelics.
The conceptual device from the London-based creative studio New Territory was specifically designed with the latter in mind. New Territory’s creative director James Ravenhall told CBD-Intel he was intrigued by the increasingly positive results coming from clinical studies into the benefits of psychedelics.